KOTLER KEVIN
Insider CIK 1601692 · AVDL Director, 10% owner · SSKN 10% owner · BDSI Director · AEGR 10% owner · PETX 10% owner · MRTX 10% owner · REPH 10% owner · CORI 10% owner · NVLN Director, 10% owner · PGNX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,685 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | J Other | 2022-03-22 | 2022-03-22 | 7,588,395 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2022-02-11 | 2022-02-15 | 436 | $10000.00 | $4.36M | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion | 2022-02-11 | 2022-02-15 | 2,422,222 | $1.80 | $4.36M | 7,588,395 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-01-31 | 15,369 | — | $0 | 15,369 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 7,685 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-01-31 | 85,760 | — | $0 | 85,760 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2022-01-27 | 2022-01-31 | 7,684 | — | $0 | 5,166,173 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-11-19 | 2021-11-22 | 100,000 | $3.06 | $306.0K | 5,158,489 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-11-12 | 2021-11-15 | 100,000 | $3.20 | $320.0K | 5,058,489 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-11-05 | 2021-11-09 | 257,800 | $3.47 | $894.6K | 4,958,489 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2021-08-10 | 2021-08-10 | 15,000 | $2.93 | $44.0K | 7,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2021-08-10 | 2021-08-10 | 15,000 | $2.93 | $44.0K | 4,700,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 15,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 4,685,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-05-13 | 2021-05-13 | 50,000 | $3.25 | $162.5K | 4,655,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-05-12 | 2021-05-13 | 100,000 | $3.24 | $324.0K | 4,605,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | P Buy | 2021-05-11 | 2021-05-13 | 150,000 | $3.16 | $474.0K | 4,505,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2020-08-07 | 2020-08-11 | 15,000 | — | $0 | 22,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2020-08-07 | 2020-08-11 | 15,000 | $2.93 | $44.0K | 4,355,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 4,340,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2020-03-17 | 2020-03-19 | 10,623 | — | $0 | 37,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2020-03-17 | 2020-03-19 | 10,623 | $2.93 | $31.1K | 4,310,689 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2019-12-20 | 2019-12-20 | 360 | $10000.00 | $3.60M | 436 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion | 2019-12-20 | 2019-12-20 | 2,000,000 | $1.80 | $3.60M | 4,300,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-12-20 | 2019-12-20 | 1,000,000 | $6.32 | $6.32M | 2,300,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-12-18 | 2019-12-20 | 750,000 | $6.50 | $4.88M | 3,300,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-12-18 | 2019-12-20 | 250,000 | $6.44 | $1.61M | 4,050,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2019-11-18 | 2019-11-19 | 720 | $10000.00 | $7.20M | 796 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion | 2019-11-18 | 2019-11-19 | 4,000,000 | $1.80 | $7.20M | 4,300,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-11-18 | 2019-11-19 | 1,500,000 | $5.90 | $8.85M | 300,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-11-18 | 2019-11-19 | 293,757 | $5.90 | $1.73M | 1,800,066 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-11-15 | 2019-11-19 | 2,206,243 | $6.04 | $13.33M | 2,093,823 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2019-08-13 | 2019-08-15 | 18,123 | — | $0 | 75,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2019-08-13 | 2019-08-15 | 18,123 | — | $0 | 4,300,066 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2019-08-07 | 2019-08-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer | 2019-07-18 | 2019-07-22 | 7,258,135 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2019-05-10 | 2019-05-14 | 324 | $10000.00 | $3.24M | 1,516 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-05-10 | 2019-05-14 | 1,800,000 | $5.00 | $9.00M | 4,281,943 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2019-04-11 | 2019-04-15 | 360 | $10000.00 | $3.60M | 1,840 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-04-11 | 2019-04-15 | 2,000,000 | $5.00 | $10.00M | 4,281,943 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2019-01-31 | 2019-02-04 | 27,900 | — | $0 | 3,130,573 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-27 | 2018-12-27 | 14,800 | $0.88 | $13.0K | 1,654,869 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-27 | 2018-12-27 | 100,000 | $0.85 | $85.0K | 1,498,553 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-27 | 2018-12-27 | 56,316 | $0.85 | $47.9K | 1,598,553 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 30,726 | $0.91 | $28.0K | 1,669,669 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 1,200 | $0.93 | $1.1K | 1,946,954 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 28,745 | $0.91 | $26.2K | 1,700,395 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 12,219 | $0.91 | $11.1K | 1,729,140 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 12,450 | $0.91 | $11.3K | 1,851,259 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 83,245 | $0.98 | $81.6K | 1,863,709 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-26 | 2018-12-27 | 109,900 | $0.87 | $95.6K | 1,741,359 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | S Sale | 2018-12-24 | 2018-12-27 | 400 | $0.98 | $392 | 1,948,154 | SEC↗ |
| CORI Corium International, Inc. | U Tender | 2018-11-27 | 2018-11-28 | 4,474,995 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2018-08-14 | 2018-08-16 | 3,124 | — | $0 | 93,123 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2018-08-14 | 2018-08-16 | 3,124 | — | $0 | 3,124 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | G Gift deriv | 2018-08-09 | 2018-08-13 | 10,000 | — | $0 | 19,600 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | G Gift deriv | 2018-08-09 | 2018-08-13 | 10,000 | — | $0 | 19,600 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 48,123 | — | $0 | 48,123 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 96,247 | — | $0 | 96,247 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-05-24 | 2018-05-24 | 38,000 | $5.99 | $227.6K | 2,168,725 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-05-24 | 2018-05-24 | 29,300 | $5.84 | $171.1K | 2,206,725 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-05-24 | 2018-05-24 | 50,000 | $5.65 | $282.5K | 2,073,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-05-24 | 2018-05-24 | 25,000 | $5.51 | $137.8K | 2,048,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-05-24 | 2018-05-24 | 45,700 | $6.00 | $274.2K | 2,123,025 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-03-15 | 2018-03-19 | 909,296 | — | $0 | 909,296 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2018-03-13 | 2018-03-15 | 200,000 | $10.07 | $2.01M | 2,236,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-21 | 2017-12-22 | 11,000 | $9.84 | $108.2K | 2,476,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-21 | 2017-12-22 | 40,000 | $9.80 | $392.0K | 2,436,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-20 | 2017-12-22 | 25,000 | $10.00 | $250.0K | 2,487,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-13 | 2017-12-14 | 8,237 | $9.80 | $80.7K | 2,512,025 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-13 | 2017-12-14 | 9,900 | $9.84 | $97.4K | 2,520,262 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-12 | 2017-12-14 | 25,000 | $10.00 | $250.0K | 2,580,262 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-12 | 2017-12-14 | 50,000 | $9.80 | $490.0K | 2,530,162 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-12 | 2017-12-14 | 100 | $9.89 | $989 | 2,580,162 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-12-05 | 2017-12-07 | 100,000 | $10.00 | $1.00M | 2,605,262 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 425,298 | $5.40 | $2.30M | 4,294,426 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 1,900 | $5.44 | $10.3K | 4,719,724 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 50,000 | $5.45 | $272.5K | 4,721,624 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 100 | $5.47 | $547 | 4,771,624 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 5,110 | $5.52 | $28.2K | 4,771,724 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 8,020 | $5.53 | $44.4K | 4,776,834 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-12-01 | 2017-12-01 | 72,000 | $5.65 | $406.8K | 4,784,854 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 100 | $9.61 | $961 | 2,705,262 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 50,000 | $9.55 | $477.5K | 2,805,362 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 5,000 | $9.62 | $48.1K | 2,855,362 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 500 | $9.69 | $4.8K | 2,860,362 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 100,000 | $9.55 | $955.0K | 2,705,362 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 6,322 | $9.63 | $60.9K | 2,860,862 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 100 | $9.71 | $971 | 2,867,184 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-30 | 2017-11-30 | 6,381 | $9.71 | $62.0K | 2,867,284 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-30 | 2017-12-01 | 11,472 | $5.97 | $68.5K | 5,056,854 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-30 | 2017-12-01 | 100 | $6.03 | $603 | 5,068,326 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-30 | 2017-12-01 | 50,000 | $5.90 | $295.0K | 4,856,854 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-30 | 2017-12-01 | 100,000 | $5.95 | $595.0K | 4,956,854 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-30 | 2017-12-01 | 50,000 | $5.95 | $297.5K | 4,906,854 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-29 | 2017-11-30 | 3,764 | $9.66 | $36.4K | 2,873,665 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-29 | 2017-11-30 | 700 | $9.68 | $6.8K | 2,877,429 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-29 | 2017-11-30 | 2,200 | $9.68 | $21.3K | 2,878,129 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 1,900 | $6.26 | $11.9K | 5,068,426 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 300 | $6.28 | $1.9K | 5,070,326 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 7,700 | $6.35 | $48.9K | 5,070,626 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 50,000 | $6.50 | $325.0K | 5,078,326 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 5,751 | $6.55 | $37.7K | 5,128,326 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 49,865 | $6.60 | $329.1K | 5,134,077 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2017-11-29 | 2017-12-01 | 1,000 | $6.66 | $6.7K | 5,183,942 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-28 | 2017-11-30 | 24,430 | $9.71 | $237.2K | 2,903,448 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-28 | 2017-11-30 | 1,500 | $9.68 | $14.5K | 2,901,948 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-28 | 2017-11-30 | 21,619 | $9.56 | $206.7K | 2,880,329 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-24 | 2017-11-24 | 5,800 | $9.39 | $54.5K | 2,935,228 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-24 | 2017-11-24 | 2,051 | $9.31 | $19.1K | 2,941,028 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-24 | 2017-11-24 | 2,913 | $9.32 | $27.1K | 2,943,079 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-24 | 2017-11-24 | 5,900 | $9.37 | $55.3K | 2,927,878 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-24 | 2017-11-24 | 1,450 | $9.48 | $13.7K | 2,933,778 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-22 | 2017-11-24 | 3,088 | $9.36 | $28.9K | 2,945,992 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-22 | 2017-11-24 | 48,566 | $9.37 | $455.1K | 2,949,080 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-21 | 2017-11-24 | 2,440 | $9.37 | $22.9K | 2,997,646 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-11-21 | 2017-11-24 | 100,000 | $9.50 | $950.0K | 3,000,086 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-17 | 2017-11-17 | 65,345 | $11.01 | $719.4K | 3,702,881 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-17 | 2017-11-17 | 100,000 | $10.95 | $1.09M | 3,602,881 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-17 | 2017-11-17 | 9,255 | $10.96 | $101.4K | 3,593,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-17 | 2017-11-17 | 25,000 | $10.95 | $273.8K | 3,568,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-16 | 2017-11-17 | 250,000 | $10.97 | $2.74M | 3,818,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-16 | 2017-11-17 | 25,000 | $10.85 | $271.3K | 3,793,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-16 | 2017-11-17 | 25,000 | $10.88 | $272.0K | 3,768,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-16 | 2017-11-17 | 400 | $10.97 | $4.4K | 3,768,226 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 60,000 | $18.05 | $1.08M | 2,728,601 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-11-02 | 2017-11-03 | 150,000 | $11.05 | $1.66M | 4,068,626 | SEC↗ |
| CORI Corium International, Inc. | S Sale | 2017-10-04 | 2017-10-06 | 218,100 | $11.01 | $2.40M | 4,218,626 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2017-06-23 | 2017-06-26 | 161,000 | $10.60 | $1.71M | 4,133,464 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2017-06-22 | 2017-06-26 | 100,000 | $10.80 | $1.08M | 4,294,464 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | X Exercise deriv | 2017-05-19 | 2017-05-22 | 7,295 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | X Exercise | 2017-05-19 | 2017-05-22 | 729,500 | $7.50 | $5.47M | 5,184,942 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-15 | 2017-02-15 | 150,000 | $9.55 | $1.43M | 6,997,269 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-14 | 2017-02-15 | 52,600 | $9.70 | $510.2K | 7,447,269 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-14 | 2017-02-15 | 150,000 | $9.68 | $1.45M | 7,147,269 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-14 | 2017-02-15 | 50,000 | $9.70 | $485.0K | 7,397,269 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-14 | 2017-02-15 | 100,000 | $9.70 | $970.0K | 7,297,269 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-13 | 2017-02-15 | 100,000 | $9.70 | $970.0K | 7,499,869 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-09 | 2017-02-09 | 1,300 | $9.69 | $12.6K | 7,599,869 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-09 | 2017-02-09 | 100,000 | $9.66 | $966.0K | 7,601,169 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-09 | 2017-02-09 | 100,000 | $9.75 | $975.0K | 7,701,169 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-07 | 2017-02-09 | 100,000 | $9.74 | $974.0K | 7,851,169 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2017-02-07 | 2017-02-09 | 50,000 | $9.65 | $482.5K | 7,801,169 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer | 2017-01-11 | 2017-01-13 | 1,000,000 | $8.95 | $8.95M | 7,951,169 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer | 2017-01-03 | 2017-01-06 | 4,394,464 | — | $0 | 0 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | G Gift deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | G Gift deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2016-12-13 | 2016-12-14 | 650,000 | $6.00 | $3.90M | 3,100,086 | SEC↗ |
| NVLN QLT INC/BC | A Award deriv | 2016-11-29 | 2016-12-01 | 2,840,909 | — | $0 | 2,840,909 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 4,472,940 | — | $0 | 9,742,771 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer | 2016-11-29 | 2016-12-01 | 4,361,291 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2016-09-13 | 2016-09-14 | 75,000 | $1.75 | $131.3K | 4,361,291 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2016-09-12 | 2016-09-12 | 76,000 | $1.70 | $129.2K | 4,286,291 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2016-09-12 | 2016-09-12 | 100,000 | $1.70 | $170.0K | 4,210,291 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2016-09-09 | 2016-09-12 | 100,000 | $1.60 | $160.0K | 4,110,291 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2016-08-16 | 2016-08-17 | 390,000 | $7.50 | $2.92M | 2,450,086 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | E Expire deriv | 2016-03-18 | 2016-03-21 | 5,000 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | X Exercise deriv | 2016-03-18 | 2016-03-21 | 4,976 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | X Exercise | 2016-03-18 | 2016-03-21 | 497,600 | $7.50 | $3.73M | 4,010,291 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | X Exercise deriv | 2016-03-17 | 2016-03-21 | 24 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | X Exercise | 2016-03-17 | 2016-03-21 | 2,400 | $7.50 | $18.0K | 3,512,691 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | S Sale | 2016-03-11 | 2016-03-14 | 200,000 | $1.28 | $256.0K | 1,008,297 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | S Sale | 2016-03-11 | 2016-03-14 | 16,000 | $1.05 | $16.8K | 1,208,297 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | S Sale | 2016-03-10 | 2016-03-14 | 25,000 | $1.50 | $37.5K | 1,224,297 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | S Sale | 2016-03-10 | 2016-03-14 | 23,500 | $1.50 | $35.3K | 1,249,297 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | S Sale | 2016-03-10 | 2016-03-14 | 1,500 | $1.51 | $2.3K | 1,272,797 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2015-11-11 | 2015-11-13 | 5,100 | $10.99 | $56.0K | 3,975,291 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2015-11-11 | 2015-11-13 | 35,000 | $10.96 | $383.6K | 4,010,291 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2015-07-07 | 2015-07-09 | 646,553 | $11.60 | $7.50M | 2,060,086 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2014-12-02 | 2014-12-04 | 241,338 | $2.50 | $603.3K | 1,413,533 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2014-07-21 | 2014-07-23 | 388,659 | $4.73 | $1.84M | 8,951,169 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2014-07-18 | 2014-07-23 | 388,200 | $4.73 | $1.84M | 8,562,510 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2014-07-17 | 2014-07-23 | 436,884 | $4.48 | $1.96M | 8,174,310 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2014-07-16 | 2014-07-23 | 411,693 | $4.48 | $1.84M | 7,737,426 | SEC↗ |